to Oslo Medtech
Register here to subscribe to our newsletter!
Generating innovation. For better living and health.
Strong start: During January Oslo Mectech-members recieved NOK 21,5 million in grants to early phase innovation projects. That is more than total grants received in 2011.
Five Oslo Medtech-members received pre-project VRI-funding.
Stavanger based Laerdal Medical and US based HealthStream launch several exciting new products through their joint venture, SimVentures.
The brand new Medtech Growth House in Oslo Innovation Center opens on the 5th of March with already ten medtech companies signed in as new tenants.
Imatis recently made tv headlines in Denmark with a story about the medtech company`s electronic boards, which proves to be very efficient in hospitals.
You will learn how medical equipment with software components must satisfy the requirements contained in IEC 62304. Of importance for those who produce medical equipment with software / IT components / electromedical equipment.
Medtech company NeoRad installed its lead product, a laser guide for image guided interventions named SimpliCT, in Hôpital Lariboisière in Paris in early January.
We kick-start the breakfast meetings “Hidden diamonds in the Norwegian Medtech Industry” Thursday; “How to position Norwegian R & D and entrepreneurial companies to achieve commercial success?”
Read more at Oslo Medtech Events. For registration click here.
Oslo Medtechs hosts a Breakfast Reception in San Francisco January 11th, at 07.00 – 08:30 AM Venue: The Stanford Court Renaissance San Francisco Hotel, 905 California Street - Nob Hill, San Francisco, CA, 94108
Medistim ASA, a Norwegian company that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces that the National Institute for Health and Clinical Excellence (NICE) today has accepted the health economics derived from routine usage of the VeriQ system for assessing graft blood flow during coronary artery bypass graft (CABG) surgery, compared to clinical assessment alone.